Quince Therapeutics, Inc.

Quince Therapeutics, Inc. is a biopharmaceutical company specializing in precision therapeutics for rare and debilitating diseases. The company has developed a bone-targeting drug platform to deliver small molecules, peptides, or large molecules directly to bone fracture and disease sites. Its lead compound, NOV004, is an anabolic peptide designed to concentrate at the bone fracture site. Quince Therapeutics, Inc. generates revenue through the development and commercialization of these precision therapeutics for bone-related conditions.